Feb 15, 2021 | Webinar

Epigenetic marker for the monitoring of bladder tumours

Watch the presentation of Dr. Fernando Lozano Palacio
(Barcelona, Spain)

During the virtual VI Symposium Liquid Biopsy, organised from 25 till 27 January 2021 by a scientific committee from the University Hospital of Santiago (Spain), Dr. Fernando Lozano Palacio from the University Hospital Vall d’Hebron (Barcelona, Spain) gave an interesting presentation about biomarkers in bladder cancer, entitled “Epigenetic marker for the monitoring of bladder tumours”.

Watch this presentation to learn more about:

  • The current follow-up of Non Muscle-Invasive Bladder Cancer (NMIBC) with some considerations and pitfalls
  • The discomfort of regular cystoscopies
  • The role of urinary markers in the follow-up of NMIBC

Other updates

Webinar on Bladder EpiCheck®, for NMIBC monitoring

On Tuesday October 6th  2020, Nucleix, Israel and Palex Medical, Spain organised the webinar “Bladder EpiCheck®, for accurate, non-invasive bladder cancer monitoring”. Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands,...

read more